Chronic granulomatous disease

Disease ID:1223
Name:Chronic granulomatous disease
Associated with:0 targets
0 immuno targets immuno relevant
1 immuno ligands
Bridges-Good syndrome | CGD | Congenital dysphagocytosis | Quie syndrome
A diverse group of potentially life-threatening hereditary diseases caused by phagocyte bactericidal dysfunction resulting in an inability to resist repeated infectious diseases and a tendency to develop chronic inflammation and widely distributed granulomas. Cross-references to several OMIM IDs.
Database Links
Disease Ontology: DOID:3265
Orphanet: ORPHA379


No target related data available for Chronic granulomatous disease


Ligand Approved Immuno References Clinical comments
IFN-γ  [ FDA (1999) ( ]
Clinical Use: Recombinant IFNγ is approved to reduce the frequency of serious infection in chronic granulomatous disease (CGD) and severe malignant osteopetrosis .
Immuno Disease Comments: Approved therapy for chronic granulomatous disease.